Wird geladen...

Biomarkers in pancreatic adenocarcinoma: current perspectives

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of 7.7%. Most patients are diagnosed at an advanced stage not amenable to potentially curative resection. A substantial portion of this review is dedicated to reviewing the current literature on carbohydrate an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Onco Targets Ther
Hauptverfasser: Swords, Douglas S, Firpo, Matthew A, Scaife, Courtney L, Mulvihill, Sean J
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5158171/
https://ncbi.nlm.nih.gov/pubmed/28003762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100510
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!